Predictors Associated With Prognosis of Patients on the Waiting List for Heart Transplantation

Aim    To identify predictors associated with the prognosis of patients on the heart transplant waiting list (HTWL) corresponding to UNOS class 2.
Material and methods    A HTWL database for 2010-2021 was retrospectively evaluated. The study included patients (n=162) who at the time of inclusion into the HTWL met UNOS class 2 and reached the endpoint of death, heart transplantation (HT), or exclusion from the HTWL due to an improvement of their condition. Mean age was 48±13 (from 11 to 67) years, 80% (n=130) were men, and body weight index was 24.9±4.4 kg/m2. Patients were divided into two groups: group 1 (n=131), patients who left the HTWL (improvement of CHF functional class) and patients who maintained the UNOS class 2 until HT; group 2 (n=31), patients who transferred from UNOS class 2 to UNOS class 1B/1A or died while on the HTWL.
Results    Patients of group 2 had lower systolic BP compared to patients of group 1 (100±17, mm Hg vs. 107±17 mm Hg, respectively, p=0.03). In group 1 compared to group 2, there was a higher proportion of patients with obesity, 29 (22%) vs. 1 (3%) (p=0.02). Laboratory blood tests: absolute lymphocyte count (2.0±0.7×109/L and 1.6±0.9×109/L, p=0.03), serum albumin (42±5 g/l and 40±6 g/l, p=0.03), red cell distribution width (RDW) (16±4% and 18±4%, p=0.01); sodium concentration (139±4 and 136±4 mmol/l, p=0.009). Patients from group 2 had a higher pulmonary vascular resistance (PVR) (4.0±2.4 Wood units vs. 3.2±1.4 Wood units, p=0.01) at baseline. A predictive model (p<0.001) was developed to determine a probability of prognosis in HTWL. The model sensitivity was 75% and the specificity was 67%. High PVR was a predictor that worsened the prognosis in HTWL; higher serum concentrations of sodium and albumin increased the probability of a favorable outcome in HTWL.
Conclusion    During the period of waiting for HT, 19% of patients that met UNOS class 2 experienced deterioration of their condition (transitioned to UNOS 1) or died. The most important predictors for a better outcome in patients on HTWL who meet UNOS class 2 were higher serum levels of sodium and albumin and low pulmonary vascular resistance.

1. Mareev V.Yu., Fomin I.V., Ageev F.T., Begrambekova Yu.L., Vasyuk Yu.A., Garganeeva A.A. et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chro nic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58(6S):8–158. DOI: 10.18087/cardio.2475

2. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021;42(36):3599–726. DOI: 10.1093/eurheartj/ehab368

3. Gautier S.V., Khomyakov S.M. Organ donation and transplantation in the Russian Federation in 2020 13th Report from the Registry of the Russian Transplant Society. Russian Journal of Transplantology and Artificial Organs. 2021;23(3):8–34. DOI: 10.15825/1995-1191-2021-3-8-34

4. Prokopova L.V., Sitnikova M.Yu. Calculator “Available prognosis” - method of evaluation for predicting survival of patients with chronic heart failure and reduced left ventricular ejection fraction. Kardiologiia. 2018;58(S5):30–6. DOI: 10.18087/cardio.2438

5. Prokopova L.V., Kashuba S.M., Galenko V.L., Fedotov P.A., Smirnov B.I., Sitnikova M.Yu. Role of simple clinico-laboratory parameters in one-year prediction of lEF HF course in the e poch of high-tech methods of health care: the available prognosis study. Russian Heart Failure Journal. 2015;16(3):137–44.

6. Hoercher KJ, Nowicki ER, Blackstone EH, Singh G, Alster JM, Gonzalez-Stawinski GV et al. Prognosis of patients removed from a transplant waiting list for medical improvement: Implications for organ allocation and transplantation for status 2 patients. The Journal of Thoracic and Cardiovascular Surgery. 2008;135(5):1159–66. DOI: 10.1016/j.jtcvs.2008.01.017

7. Pueschner A, Chattranukulchai P, Heitner JF, Shah DJ, Hayes B, Rehwald W et al. The Prevalence, Correlates, and Impact on Cardiac Mortality of Right Ventricular Dysfunction in Nonischemic Cardiomyopathy. JACC: Cardiovascular Imaging. 2017;10(10 Pt B):1225–36. DOI: 10.1016/j.jcmg.2017.06.013

8. Khazova E.V., Bulashova O.V., Amirov N.B. Hypoalbuminemia and chronic heart failure. The Bulletin of Contemporary Clinical Medicine. 2019;12(4):80–5. DOI: 10.20969/VSKM.2019.12(4).80-85

9. Madan VD, Novak E, Rich MW. Impact of Change in Serum Sodium Concentration on Mortality in Patients Hospitalized With Heart Failure and Hyponatremia. Circulation: Heart Failure. 2011;4(5):637–43. DOI: 10.1161/CIRCHEARTFAILURE.111.961011

10. Rusinaru D, Tribouilloy C, Berry C, Richards AM, Whalley GA, Earle N et al. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis: Meta-Analysis Global Group in Chronic heart failure (MAGGIC). European Journal of Heart Failure. 2012;14(10):1139–46. DOI: 10.1093/eurjhf/hfs099

11. Simonenko M. Obesity paradox in heart failure: A matter of debate. European Journal of Preventive Cardiology. 2019;26(16):1748–50. DOI: 10.1177/2047487319861473

12. Cautela J, Tartiere J, Cohen-Solal A, Bellemain-Appaix A, Theron A, Tibi T et al. Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients. European Journal of Heart Failure. 2020;22(8):1357–65. DOI: 10.1002/ejhf.1835

13. Vinogradova N.G., Polyakov D.S., Fomin I.V. Analysis of mortality in patients with heart failure after decompen sation during long-term follow-up in specialized medical care and in real clinical practice. Kardiologiia. 2020;60(4):91–100. DOI: 10.18087/cardio.2020.4.n1014

14. Szwejkowski BR, Elder DHJ, Shearer F, Jack D, Choy AMJ, Pringle SD et al. Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study. European Journal of Heart Failure. 2012;14(2):162–7. DOI: 10.1093/eurjhf/hfr159

15. Dzudie A, Kengne AP, Thienemann F, Sliwa K. Predictors of hospitalisations for heart failure and mortality in patients with pulmonary hypertension associated with left heart disease: a systematic review. BMJ Open. 2014;4(7):e004843. DOI: 10.1136/bmjopen-2014-004843